Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Grey Wolf HealthTSXV:WOLF 56 Earnings per Share (Diluted) is C$0.05 as of Jun. 2026. GuruFocus rates TSXV:WOLF with a GF Score™ of 56/100 and a GF Value™ of C$1.19 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 503 Healthcare Providers & Services companies, Grey Wolf Health ranks worse than 198806.96% on this metric.
Grey Wolf Health's EPS (Basic) for the
three
months ended in Jun. 2026 was C$0.02.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2026 was C$0.05.
Grey Wolf Health (TSXV:WOLF) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Grey Wolf Health Earnings per Share (Diluted) Related Terms
Grey Wolf Health Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for Grey Wolf Health's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Grey Wolf Health Earnings per Share (Diluted) Chart
Grey Wolf Health Earnings per Share (Diluted) Competitor Comparison
For the Pharmaceutical Retailers subindustry, Grey Wolf Health's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Grey Wolf Health PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Grey Wolf Health's PE Ratio distribution charts can be found below:
* The bar in red indicates where Grey Wolf Health's PE Ratio falls into.
Grey Wolf Health Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Grey Wolf Health's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2025 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.05
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of C$0.05 mean?
Grey Wolf Health (TSXV:WOLF) has a Earnings per Share (Diluted) of C$0.05 as of Jun. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Grey Wolf Health and its competitors. According to the industry distribution chart, Grey Wolf Health ranks #999999 out of 503 companies in the Healthcare Providers & Services industry.
Is Grey Wolf Health's Earnings per Share (Diluted) too high?
Grey Wolf Health's current Earnings per Share (Diluted) is C$0.05. Based on the distribution chart, Grey Wolf Health ranks #999999 out of 503 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Grey Wolf Health has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Grey Wolf Health's Earnings per Share (Diluted) compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Grey Wolf Health ranks #999999 out of 503 companies for Earnings per Share (Diluted). This places Grey Wolf Health in the lower half of its industry. The industry median Earnings per Share (Diluted) is 11.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Healthcare Providers & Services company?
The median Earnings per Share (Diluted) among Healthcare Providers & Services companies is 11.00, based on 503 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Grey Wolf Health and its competitors. For the Healthcare Providers & Services industry, the median Earnings per Share (Diluted) is 11.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grey Wolf Health's current Earnings per Share (Diluted) is C$0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grey Wolf Health stock overvalued right now?
Based on GuruFocus' analysis, Grey Wolf Health (TSXV:WOLF) is currently considered Significantly Overvalued. The stock's GF Value™ is C$1.19, compared to a current price of C$1.70 — trading 42.9% above its estimated fair value. The current Earnings per Share (Diluted) is C$0.05. Grey Wolf Health's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Grey Wolf Health (TSXV:WOLF), the current Earnings per Share (Diluted) is C$0.05 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Grey Wolf Health (TSXV:WOLF) Overvalued in 2026?
Based on GuruFocus' analysis, Grey Wolf Health stock appears to be overvalued.
The current stock price of C$1.70 is trading 42.9% above its estimated GF Value™ of C$1.19.
GuruFocus considers Grey Wolf Health to be Significantly Overvalued.
Key valuation signals for TSXV:WOLF:
Earnings per Share (Diluted): C$0.05
GF Value™: C$1.19 vs. price of C$1.70 (42.9% above fair value)
No single metric tells the full story. See the TSXV:WOLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Grey Wolf Animal Health Corp focuses on sourcing, in-licensing, acquiring, and compounding branded and generic products for sale in both animal and human health markets in Canada. The Company operates through two reportable segments: the Animal Health segment, which involves the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics across Canada; and the Pharmacy segment, which generates the majority of revenue and focuses on compounding pharmaceuticals for both human and animal health markets.
56GF Score
Get the complete analysis for TSXV:WOLF
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:WOLF has been successfully added to your 
